The Role of Systematic Reviews in Pharmacovigilance Planning and Clinical Trials Authorisation Application: Example from the SLEEPS Trial

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Gamble, Carrol ^a   Wolf, Andrew ^b   Sinha, Ian ^c   Spowart, Catherine ^a   Williamson, Paula ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^c ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; MIDAZOLAM; PROPOFOL;

ADULT; AGITATION; ARTICLE; AUDITORY HALLUCINATION; CAUSAL ATTRIBUTION; CHILD; CHOREOATHETOSIS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTINUOUS INFUSION; DIARRHEA; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DYSKINESIA; HUMAN; HYPERLIPIDEMIA; HYPERPYREXIA; INFANT; INSOMNIA; IRRITABILITY; MECHANICAL VENTILATOR; METABOLIC ACIDOSIS; MOTOR DYSFUNCTION; MYOCLONUS; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; PATHOLOGICAL CRYING; PATIENT MONITORING; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEDATION; SIDE EFFECT; SLEEP DISORDER; SWEATING; SYSTEMATIC REVIEW; TACHYPNEA; TREATMENT DURATION; TREATMENT PLANNING; TREMOR; VISUAL HALLUCINATION; VOMITING; WITHDRAWAL SYNDROME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CLONIDINE; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; MALE; MIDAZOLAM; PHARMACOVIGILANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SYMPATHOLYTICS;

EID: 84875023185     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051787     Document Type: Article

References (103)

1. Tobias JD, (2000) Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Critical Care Medicine 28: 2122-2132.
2. Anand KJ, Hansen DD, Hickey PR, (1990) Hormonal-metabolic stress responses in neonates undergoing cardiac surgery. Anesthesiology 73: 661-670.
3. Anand KJ, Hickey PR, (1992) Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery.[see comment]. New England Journal of Medicine 326: 1-9.
4. Tobias JD, Rasmussen GE, (1994) Pain management and sedation in the pediatric intensive care unit. Pediatric Clinics of North America 41: 1269-1292.
5. Wolf AR, (1994) Neonatal sedation: more art than science.[comment]. Lancet 344: 628-629.
6. Jenkins IA, Playfor SD, Bevan C, Davies G, Wolf AR, (2007) Current United Kingdom sedation practice in pediatric intensive care. Paediatric Anaesthesia 17: 675-683.
7. Playfor SD, Thomas DA, Choonara I, (2003) Sedation and neuromuscular blockade in paediatric intensive care: a review of current practice in the UK. Paediatric Anaesthesia 13: 147-151.
8. Harte GJ, Gray PH, Lee TC, Steer PA, Charles BG, (1997) Haemodynamic responses and population pharmacokinetics of midazolam following administration to ventilated, preterm neonates. Journal of Paediatrics & Child Health 33: 335-338.
9. van Straaten HL, Rademaker CM, de Vries LS, (1992) Comparison of the effect of midazolam or vecuronium on blood pressure and cerebral blood flow velocity in the premature newborn. Developmental Pharmacology & Therapeutics 19: 191-195.
10. Ng E, Taddio A, Ohlsson A, (2003) Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.[update of Cochrane Database Syst Rev. 2000;(2):CD002052; PMID: 10796280]. Cochrane Database of Systematic Reviews pp. CD002052.
11. Clarke L, Clarke M, Clarke T, (2007) How useful are Cochrane reviews in identifying research needs? J Health Serv Res Policy 2007;12(2):101-3. J Health Serv Res Policy 12: 101-103.
12. Goudie A, Sutton A, Jones D, Donald A, (2010) Empirical assessment suggests that existing evidence could be used more fully in designing randomized controlled trials. Journal of Clinical Epidemiology 63: 983-991.
13. Clarke M, Hopewell S, Chalmers I, (2010) Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting. Lancet 376: 20-21.
14. Cooper N, Jones D, Sutton A, (2005) The use of systematic reviews when designing studies. Clinical Trials 2: 260-264.
15. Aranda JV, Carlo W, Hummel P, Thomas R, Lehr VT, et al. (2005) Analgesia and sedation during mechanical ventilation in neonates. Clinical Therapeutics 27: 877-899.
16. Ista E, van Dijk M, Gamel C, Tibboel D, de Hoog M, (2007) Withdrawal symptoms in children after long-term administration of sedatives and/or analgesics: a literature review. "Assessment remains troublesome". Intensive Care Medicine 33: 1396-1406.
17. Kirkham JJ, Dwan K, Dodd S, Altman DG, Smyth R, et al. (2010) The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 340: c365.
18. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, et al. (1981) A method for estimating the probability of adverse drug reactions. Clinical Pharmacology & Therapeutics 30: 239-245.
19. van Alfen-van der Velden AAEM, Hopman JCW, Klaessens JHGM, Feuth T, Sengers RCA, et al. (2006) Effects of midazolam and morphine on cerebral oxygenation and hemodynamics in ventilated premature infants. Biology of the Neonate 90: 197-202.
20. Treluyer JM, Zohar S, Rey E, Hubert P, Iserin F, et al. (2005) Minimum effective dose of midazolam for sedation of mechanically ventilated neonates. Journal of Clinical Pharmacy & Therapeutics 30: 479-485.
21. Tobias JD, Berkenbosch JW, (2004) Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. Southern Medical Journal 97: 451-455.
22. Arya V, Ramji S, (2001) Midazolam sedation in mechanically ventilated newborns: a double blind randomized placebo controlled trial.[see comment]. Indian Pediatrics 38: 967-972.
23. Anand KJ, Barton BA, McIntosh N, Lagercrantz H, Pelausa E, et al. (1999) Analgesia and sedation in preterm neonates who require ventilatory support: results from the NOPAIN trial. Neonatal Outcome and Prolonged Analgesia in Neonates.[erratum appears in Arch Pediatr Adolesc Med 1999 Aug;153(8):895]. Archives of Pediatrics & Adolescent Medicine 153: 331-338.
24. Parkinson L, Hughes J, Gill A, Billingham I, Ratcliffe J, et al. (1997) A randomized controlled trial of sedation in the critically ill. Paediatric Anaesthesia 7: 405-410.
25. Jacqz-Aigrain E, Daoud P, Burtin P, Desplanques L, Beaufils F, (1994) Placebo-controlled trial of midazolam sedation in mechanically ventilated newborn babies.[see comment]. Lancet 344: 646-650.
26. Ista E, van Dijk M, Gamel C, Tibboel D, de Hoog M, (2008) Withdrawal symptoms in critically ill children after long-term administration of sedatives and/or analgesics: a first evaluation.[see comment]. Critical Care Medicine 36: 2427-2432.
27. Ducharme C, Carnevale FA, Clermont M-S, Shea S, (2005) A prospective study of adverse reactions to the weaning of opioids and benzodiazepines among critically ill children. Intensive & Critical Care Nursing 21: 179-186.
28. Franck LS, Naughton I, Winter I, (2004) Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients. Intensive & Critical Care Nursing 20: 344-351.
29. Sheridan RL, Keaney T, Stoddard F, Enfanto R, Kadillack P, et al. (2003) Short-term propofol infusion as an adjunct to extubation in burned children. Journal of Burn Care & Rehabilitation 24: 356-360.
30. Sheridan R, Stoddard F, Querzoli E, (2001) Management of background pain and anxiety in critically burned children requiring protracted mechanical ventilation. Journal of Burn Care & Rehabilitation 22: 150-153.
31. Fonsmark L, Rasmussen YH, Carl P, (1999) Occurrence of withdrawal in critically ill sedated children.[see comment]. Critical Care Medicine 27: 196-199.
32. Pepperman ML, Macrae D, (1997) A comparison of propofol and other sedative use in paediatric intensive care in the United Kingdom. Paediatric Anaesthesia 7: 143-153.
33. Shekerdemian L, Bush A, Redington A, (1997) Cardiovascular effects of intravenous midazolam after open heart surgery. Archives of Disease in Childhood 76: 57-61.
34. Hughes J, Gill A, Leach HJ, Nunn AJ, Billingham I, et al. (1994) A prospective study of the adverse effects of midazolam on withdrawal in critically ill children. Acta Paediatrica 83: 1194-1199.
35. Sheridan RL, McEttrick M, Bacha G, Stoddard F, Tompkins RG, (1994) Midazolam infusion in pediatric patients with burns who are undergoing mechanical ventilation. Journal of Burn Care & Rehabilitation 15: 515-518.
36. Jacqz-Aigrain E, Daoud P, Burtin P, Maherzi S, Beaufils F, (1992) Pharmacokinetics of midazolam during continuous infusion in critically ill neonates. European Journal of Clinical Pharmacology 42: 329-332.
37. Rosen DA, Rosen KR, (1991) Midazolam for sedation in the paediatric intensive care unit. Intensive Care Medicine 17 (Suppl 1):: S15-19.
38. Bergman I, Steeves M, Burckart G, Thompson A, (1991) Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration.[see comment]. Journal of Pediatrics 119: 644-649.
39. Hartwig S, Roth B, Theisohn M, (1991) Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit. European Journal of Pediatrics 150: 784-788.
40. Booker PD, Beechey A, Lloyd-Thomas AR, (1986) Sedation of children requiring artificial ventilation using an infusion of midazolam. British Journal of Anaesthesia 58: 1104-1108.
41. Epstein D, Difazio M, (2007) Orofacial automatisms induced by acute withdrawal from high-dose midazolam mimicking nonconvulsive status epilepticus in a child. Movement Disorders 22: 712-715.
42. Cho HH, O'Connell JP, Cooney MF, Inchiosa MA Jr, (2007) Minimizing tolerance and withdrawal to prolonged pediatric sedation: case report and review of the literature. Journal of Intensive Care Medicine 22: 173-179.
43. Biswas AK, Feldman BL, Davis DH, Zintz EA, (2005) Myocardial ischemia as a result of severe benzodiazepine and opioid withdrawal. Clinical Toxicology: The Official Journal of the American Academy of Clinical Toxicology & European Association of Poisons Centres & Clinical Toxicologists 43: 207-209.
44. Carnevale FA, Ducharme C, (1997) Adverse reactions to the withdrawal of opioids and benzodiazepines in paediatric intensive care. Intensive & Critical Care Nursing 13: 181-188.
45. Yaster M, Kost-Byerly S, Berde C, Billet C, (1996) The management of opioid and benzodiazepine dependence in infants, children, and adolescents. Pediatrics 98: 135-140.
46. Ducharme MP, Munzenberger P, (1995) Severe withdrawal syndrome possibly associated with cessation of a midazolam and fentanyl infusion. Pharmacotherapy 15: 665-668.
47. Tobias JD, Deshpande JK, Gregory DF, (1994) Outpatient therapy of iatrogenic drug dependency following prolonged sedation in the pediatric intensive care unit. Intensive Care Medicine 20: 504-507.
48. van Engelen BG, Gimbrere JS, Booy LH, (1993) Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam. Annals of Pharmacotherapy 27: 579-581.
49. Sury MR, Billingham I, Russell GN, Hopkins CS, Thornington R, et al. (1989) Acute benzodiazepine withdrawal syndrome after midazolam infusions in children.[see comment]. Critical Care Medicine 17: 301-302.
50. Lloyd-Thomas AR, Booker PD, (1986) Infusion of midazolam in paediatric patients after cardiac surgery. British Journal of Anaesthesia 58: 1109-1115.
51. Ambrose C, Sale S, Howells R, Bevan C, Jenkins I, et al. (2000) Intravenous clonidine infusion in critically ill children: dose-dependent sedative effects and cardiovascular stability. British Journal of Anaesthesia 84: 794-796.
52. Lyons B, Casey W, Doherty P, McHugh M, Moore K, (1996) Pain relief with low-dose intravenous clonidine in a child with severe burns. Intensive Care Medicine 22: 249-251.
53. Loke YK, Price D, Herxheimer A, Cochrane Adverse Effects Methods G, (2007) Systematic reviews of adverse effects: framework for a structured approach. BMC Medical Research Methodology 7: 32.
54. Sinha I, Jones L, Smyth RL, Williamson PR, (2008) A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Medicine/Public Library of Science 5: e96.
55. Anand KJS, Aranda JV, Berde CB, Buckman S, Capparelli EV, et al. (2006) Summary proceedings from the neonatal pain-control group. Pediatrics 117: S9-S22.
56. Easley RB, Nichols DG, (2008) Withdrawal assessment in the pediatric intensive care unit: quantifying a morbidity of pain and sedation management in the critically ill child.[comment]. Critical Care Medicine 36: 2479-2480.
57. MRC/DH joint project Clinical Trials Toolkit (2007) Work stream 6: Pharmacovigilance. Available: http://www.ct-toolkit.ac.uk/_db/_documents/Joint_Project_Guidance_on_Pharmacovigilance.pdf: Accessed: 12th December 2012.
58. Aitkenhead AR, Pepperman ML, Willatts SM, Coates PD, Park GR, et al. (1989) Comparison of propofol and midazolam for sedation in critically ill patients. Lancet 2: 704-709.
59. Bourgoin A, Albanese J, Wereszczynski N, Charbit M, Vialet R, et al. (2003) Safety of sedation with ketamine in severe head injury patients: comparison with sufentanil. Critical Care Medicine 31: 711-717.
60. Cernaianu AC, DelRossi AJ, Flum DR, Vassilidze TV, Ross SE, et al. (1996) Lorazepam and midazolam in the intensive care unit: a randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy, and cost. Critical Care Medicine 24: 222-228.
61. Chamorro C, de Latorre FJ, Montero A, Sanchez-Izquierdo JA, Jareno A, et al. (1996) Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial.[see comment]. Critical Care Medicine 24: 932-939.
62. Costa J, Cabre L, Molina R, Carrasco G, (1994) Cost of ICU sedation: comparison of empirical and controlled sedation methods. Clinical Intensive Care 5: 17-21.
63. Deo S, Knottenbelt JD, (1994) The use of midazolam in trauma resuscitation. European Journal of Emergency Medicine 1: 111-114.
64. Dirksen MS, Vree TB, Driessen JJ, (1987) Clinical pharmacokinetics of long-term infusion of midazolam in critically ill patients-preliminary results. Anaesthesia & Intensive Care 15: 440-444.
65. Flogel CM, Ward DS, Wada DR, Ritter JW, (1993) The effects of large-dose flumazenil on midazolam-induced ventilatory depression. Anesthesia & Analgesia 77: 1207-1214.
66. Lee Y, Wang JJ, Yang YL, Chen A, Lai HY, (2007) Midazolam vs ondansetron for preventing postoperative nausea and vomiting: a randomised controlled trial.[see comment]. Anaesthesia 62: 18-22.
67. Lescot T, Pereira AR, Abdennour L, Sanchez-Pena P, Naccache L, et al. (2007) Effect of loxapine on electrical brain activity, intracranial pressure, and middle cerebral artery flow velocity in traumatic brain-injured patients. Neurocritical Care 7: 124-127.
68. Searle NR, Cote S, Taillefer J, Carrier M, Gagnon L, et al. (1997) Propofol or midazolam for sedation and early extubation following cardiac surgery. Canadian Journal of Anaesthesia 44: 629-635.
69. Sinclair ME, Sear JW, Summerfield RJ, Fisher A, (1988) Alfentanil infusions on the intensive therapy unit. Intensive Care Medicine 14: 55-59.
70. Stewart L, Bullock R, Teasdale GM, Wagstaff A, (1999) First observations of the safety and tolerability of a competitive antagonist to the glutamate NMDA receptor (CGS 19755) in patients with severe head injury. Journal of Neurotrauma 16: 843-850.
71. Tanigami H, Yahagi N, Kumon K, Watanabe Y, Haruna M, et al. (1997) Long-term sedation with isoflurane in postoperative intensive care in cardiac surgery. Artificial Organs 21: 21-23.
72. Bitar G, Mullis W, Jacobs W, Matthews D, Beasley M, et al. (2003) Safety and efficacy of office-based surgery with monitored anesthesia care/sedation in 4778 consecutive plastic surgery procedures.[see comment]. Plastic & Reconstructive Surgery 111: 150-156; discussion 157-158.
73. Djurberg H, Pothmann Facharzt W, Joseph D, Tjan D, Zuleika M, et al. (2002) Anesthesia care for living-related liver transplantation for infants and children with end-stage liver disease: report of our initial experience. Journal of Clinical Anesthesia 14: 564-570.
74. Hertzog JH, Campbell JK, Dalton HJ, Hauser GJ, (1999) Propofol anesthesia for invasive procedures in ambulatory and hospitalized children: experience in the pediatric intensive care unit. Pediatrics 103: E30.
75. Hickey PR, Wessel DL, Streitz SL, Fox ML, Kern FH, et al. (1992) Transcatheter closure of atrial septal defects: hemodynamic complications and anesthetic management. Anesthesia & Analgesia 74: 44-50.
76. Koroglu A, Demirbilek S, Teksan H, Sagir O, But AK, et al. (2005) Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. British Journal of Anaesthesia 94: 821-824.
77. Laussen PC, Hansen DD, Perry SB, Fox ML, Javorski JJ, et al. (1995) Transcatheter closure of ventricular septal defects: hemodynamic instability and anesthetic management. Anesthesia & Analgesia 80: 1076-1082.
78. Malagon I, Hogenbirk K, van Pelt J, Hazekamp MG, Bovill JG, (2005) Effect of three different anaesthetic agents on the postoperative production of cardiac troponin T in paediatric cardiac surgery. British Journal of Anaesthesia 94: 805-809.
79. Somri M, Tome R, Yanovski B, Asfandiarov E, Carmi N, et al. (2007) Combined spinal-epidural anesthesia in major abdominal surgery in high-risk neonates and infants. Paediatric Anaesthesia 17: 1059-1065.
80. Wilson KE, Girdler NM, Welbury RR, (2003) Randomized, controlled, cross-over clinical trial comparing intravenous midazolam sedation with nitrous oxide sedation in children undergoing dental extractions. British Journal of Anaesthesia 91: 850-856.
81. Yldzdas D, Yapcoglu H, Ylmaz HL, (2004) The value of capnography during sedation or sedation/analgesia in pediatric minor procedures. Pediatric Emergency Care 20: 162-165.
82. Gruber EM, Laussen PC, Casta A, Zimmerman AA, Zurakowski D, et al. (2001) Stress response in infants undergoing cardiac surgery: a randomized study of fentanyl bolus, fentanyl infusion, and fentanyl-midazolam infusion.[see comment]. Anesthesia & Analgesia 92: 882-890.
83. Hartvig P, Larsson E, Joachimsson PO, (1993) Postoperative analgesia and sedation following pediatric cardiac surgery using a constant infusion of ketamine. Journal of Cardiothoracic & Vascular Anesthesia 7: 148-153.
84. Prins SA, Peeters MYM, Houmes RJ, van Dijk M, Knibbe CAJ, et al. (2005) Propofol 6% as sedative in children under 2 years of age following major craniofacial surgery. British Journal of Anaesthesia 94: 630-635.
85. De Cosmo G, Congedo E, Clemente A, Aceto P, (2005) Sedation in PACU: the role of propofol. Current Drug Targets 6: 741-744.
86. Walker J, Maccallum M, Fischer C, Kopcha R, Saylors R, et al. (2006) Sedation using dexmedetomidine in pediatric burn patients. Journal of Burn Care & Research 27: 206-210.
87. Notterman DA, (1997) Sedation with intravenous midazolam in the pediatric intensive care unit. Clinical Pediatrics 36: 449-454.
88. Al-Samsam RH, Cullen P, (2005) Sleep and adverse environmental factors in sedated mechanically ventilated pediatric intensive care patients. Pediatric Critical Care Medicine 6: 562-567.
89. Buck ML, Willson DF, (2008) Use of dexmedetomidine in the pediatric intensive care unit. Pharmacotherapy 28: 51-57.
90. DeBerry BB, Lynch JE, Chernin JM, Zwischenberger JB, Chung DH, (2005) A survey for pain and sedation medications in pediatric patients during extracorporeal membrane oxygenation. Perfusion 20: 139-143.
91. Enomoto Y, Kudo T, Saito T, Hori T, Kaneko M, et al. (2006) Prolonged use of dexmedetomidine in an infant with respiratory failure following living donor liver transplantation. Paediatric Anaesthesia 16: 1285-1288.
92. Jin HS, Yum MS, Kim SL, Shin HY, Lee EH, et al. (2007) The efficacy of the COMFORT scale in assessing optimal sedation in critically ill children requiring mechanical ventilation. Journal of Korean Medical Science 22: 693-697.
93. Kadilak PR, Vanasse S, Sheridan RL, (2004) Favorable short- and long-term outcomes of prolonged translaryngeal intubation in critically ill children. Journal of Burn Care & Rehabilitation 25: 262-265.
94. Lugo RA, Chester EA, Cash J, Grant MJ, Vernon DD, (1999) A cost analysis of enterally administered lorazepam in the pediatric intensive care unit.[see comment]. Critical Care Medicine 27: 417-421.
95. Playfor SD, Thomas DA, Choonara I, Jarvis A, (2000) Quality of sedation during mechanical ventilation. Paediatric Anaesthesia 10: 195-199.
96. Rigby-Jones AE, Priston MJ, Sneyd JR, McCabe AP, Davis GI, et al. (2007) Remifentanil-midazolam sedation for paediatric patients receiving mechanical ventilation after cardiac surgery. British Journal of Anaesthesia 99: 252-261.
97. Saha AS, Langridge P, Playfor SD, (2006) The pattern of intravenous drug administration during the transfer of critically ill children by a specialist transport team. Paediatric Anaesthesia 16: 1063-1067.
98. Schmidt B, Roth B, Stutzer H, Benz-Bohm G, (2006) Prospective sonographic evaluation of fentanyl side effects on the neonatal gallbladder. European Journal of Clinical Pharmacology 62: 823-827.
99. Vernon DD, Witte MK, (2000) Effect of neuromuscular blockade on oxygen consumption and energy expenditure in sedated, mechanically ventilated children. Critical Care Medicine 28: 1569-1571.
100. Prause A, Wappler F, Scholz J, Bause H, Schulte am Esch J, (2000) Respiratory depression under long-term sedation with sufentanil, midazolam and clonidine has no clinical significance. Intensive Care Medicine 26: 1454-1461.
101. Shelly MP, Sultan MA, Bodenham A, Park GR, (1991) Midazolam infusions in critically ill patients. European Journal of Anaesthesiology 8: 21-27.
102. Artman M, Boerth R, (1983) Clonidine Poisoning. A Complex Problem. American Journal of Diseases of Children 137: 171-174.
103. Tanaka M, Nishikawa T, (1995) Effects of clonidine premedication on the pressor response to α-adrenergic agonists. British Journal of Anaesthesia 75: 593-597.